2 completed, 2 enrolling by invitation, 1 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Enrolling by invitation 2, Terminated 1 |
Follow Primary Breast Cancer: new trials by email Literature Review of Primary Breast Cancer trials Research Report on Primary Breast Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107 Injection of [99mTc]Tc-ZHER2:4107, SPECT/CT - Primary Breast Cancer | Phase 2 | Enrolling by invitation | Tomsk National Research Medical Center of the Russian Academy of Sciences | 50 | 2025-10-20 | 2026-06-24 |
| [99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression [99mTc]Tc-DB8 - Primary Breast Cancer | Phase 2 | Enrolling by invitation | Tomsk National Research Medical Center of the Russian Academy of Sciences | 40 | 2025-10-01 | 2026-06-24 |
| Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE) Cabacitaxel, Paclitaxel - Primary Breast Cancer | Phase 2 | Completed | GBG Forschungs GmbH | 333 | 2013-02-01 | 2017-08-01 |
| Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel Epirubicin, Carboplatin, Docetaxel - Primary Breast Cancer | Phase 2 | Completed | Klinikum Weissenfels | 50 | 2006-05-01 | 2010-01-15 |
| Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow Zoledronic acid + Calcium/Vitamin D - Primary Breast Cancer | Phase 2 | Terminated | Novartis Pharmaceuticals | 96 | 2002-01-01 | 2009-12-23 |
Breast Neoplasms (3) · Neoplasm, Residual (1)
Neoplasms (4) · Breast Diseases (3) · Neoplasms by Site (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Calcium (1) · Carboplatin (1) · Docetaxel (1) · Epirubicin (1) · Paclitaxel (1) · Vitamin D (1) · Zoledronic Acid (1)
Tomsk National Research Medical Center of the Russian Academy of Sciences (2) · GBG Forschungs GmbH (1) · Klinikum Weissenfels (1) · Novartis Pharmaceuticals (1)
Germany (3) · Russia (2)
Vladimir I Chernov, MD, Prof (2) · Dieter Lampe, Dr. med. (1) · Gunter von Minckwitz, Prof. Dr. (1)